Wednesday, September 23, 2026

USD/EUR Is 1% Down In The Last 21 Sessions

USD/EUR Is 1% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.99% for the last 21 sessions. At 01:07 EST on Thursday, 22 June, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 0.954% up from its 52-week low and 13.185% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.51%, a negative 0.09%, and a positive 0.37%, respectively.

USD/EUR's highest amplitude of average volatility was 0.61% (last week), 0.32% (last month), and 0.37% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy eases after refreshing yearly top above 142.00 as yields dribble amid full markets. According to FXStreet on Tuesday, 20 June, "However, the People's Bank of China's (PBoC) rate cut and Japan Finance Minister (FinMin) Shunichi Suzuki's comments appear to prod the market sentiment, US Treasury bond yields and the USD/JPY prices of late.", "Moving on, USD/JPY is likely to remain firmer but the second-tier US housing data, Japan Industrial Production for April and Fed versus BoJ updates will be the key to watch for the clear directions."
  • Usd/jpy consolidates around 142.00 mark, just below YTD high set this Tuesday. According to FXStreet on Tuesday, 20 June, "This, in turn, triggers a fresh leg up in the US Treasury bond yields, which allows the USD to capitalize on its recent recovery from over a one-month low touched last Friday and further acts as a tailwind for the USD/JPY pair. ", "The USD/JPY pair reverses an intraday dip and trades around the 142.00 mark during the early European session, just below its highest level since November 2022 touched earlier this Tuesday."
  • Usd/jpy technical analysis: overbought levels - 20 June 2023. According to DailyForex on Tuesday, 20 June, "For three consecutive trading sessions, the price of the USD/JPY currency pair stabilized around its recent strong gains. ", "Forecasts of the US dollar against the Japanese yen today:The general trend of the USD/JPY currency pair is still bullish."
  • Usd/jpy: FX intervention unlikely until 145 – socgen. According to FXStreet on Tuesday, 20 June, "A further widening of UST/JGB differentials in the run-up to the July meeting and acceleration of USD/JPY beyond 145 could see the return of FX intervention."
  • Usd/jpy price analysis: bears eye a run to test 141 the figure. According to FXStreet on Tuesday, 20 June, "USTreasury yields also eased but USD/JPY fell to 141.21 from a high of 142.25 nonetheless. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com